Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 11988058)

1.

Benefits and costs of using HPV testing to screen for cervical cancer.

Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.

JAMA. 2002 May 8;287(18):2372-81.

PMID:
11988058
2.

The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.

Holmes J, Hemmett L, Garfield S.

Eur J Health Econ. 2005 Mar;6(1):30-7. Review.

PMID:
15682286
3.

HPV testing in cervical screening.

Cuzick J.

Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. Review. No abstract available.

PMID:
11417064
4.

Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health.

Mühlberger N, Sroczynski G, Esteban E, Mittendorf T, Miksad RA, Siebert U.

Int J Technol Assess Health Care. 2008 Spring;24(2):184-92. doi: 10.1017/S0266462308080264. Review.

PMID:
18400122
5.

Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.

Franco EL.

J Natl Cancer Inst Monogr. 2003;(31):89-96. Review.

PMID:
12807951
6.

Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.

Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU.

Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5. doi: 10.7326/0003-4819-155-10-201111150-00376. Epub 2011 Oct 17. Review. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71-2.

PMID:
22006930
7.

Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].

Kulasingam SL, Havrilesky L, Ghebre R, Myers ER.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May.

8.

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ.

Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Review.

PMID:
18847555
9.

Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.

Cox JT.

Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S15-25. Review.

PMID:
16729900
10.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
11.

New technologies for cervical cancer screening.

Brown AJ, Trimble CL.

Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):233-42. doi: 10.1016/j.bpobgyn.2011.11.001. Epub 2011 Nov 25. Review.

12.

Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.

Widdice LE, Moscicki AB.

J Adolesc Health. 2008 Oct;43(4 Suppl):S41-51. doi: 10.1016/j.jadohealth.2008.04.007. Epub 2008 Jul 23. Review.

13.

Delaying Pap test screening in the adolescent population: an evidence-based approach.

Spiryda LB, Brown J, Zhang H, Burgis JT.

J Pediatr Adolesc Gynecol. 2014 Feb;27(1):3-5. doi: 10.1016/j.jpag.2013.03.008. Epub 2013 May 29. Review.

PMID:
23726136
14.

Cervical cancer prevention: immunization and screening 2015.

Thaxton L, Waxman AG.

Med Clin North Am. 2015 May;99(3):469-77. doi: 10.1016/j.mcna.2015.01.003. Epub 2015 Feb 28. Review.

PMID:
25841595
15.

[Cervical cancer screening in Switzerland - current practice and future challenges].

Untiet S, Schmidt N, Low N, Petignat P.

Ther Umsch. 2013 Apr;70(4):223-30. doi: 10.1024/0040-5930/a000393. Review. German.

PMID:
23535549
16.

Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential.

Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH.

Cancer Prev Res (Phila). 2012 Jan;5(1):11-7. doi: 10.1158/1940-6207.CAPR-11-0540. Epub 2011 Dec 12. Review.

17.

Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?

Kauffman RP, Griffin SJ, Lund JD, Tullar PE.

Med Princ Pract. 2013;22(4):313-22. doi: 10.1159/000346137. Epub 2013 Jan 15. Review.

PMID:
23328247
18.

A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking.

Nahvijou A, Hadji M, Marnani AB, Tourang F, Bayat N, Weiderpass E, Daroudi R, Sari AA, Zendehdel K.

Asian Pac J Cancer Prev. 2014;15(19):8229-37. Review.

19.

Screening for cervical cancer using automated analysis of PAP-smears.

Bengtsson E, Malm P.

Comput Math Methods Med. 2014;2014:842037. doi: 10.1155/2014/842037. Epub 2014 Mar 20. Review.

20.

Benefit assessment of HPV testing in primary screening for cervical cancer: Executive summary of final report S10-01, Version 1.0.

Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005-.
2011 Nov 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk